Opportunities

Istesso

Istesso is a drug development company working in the field of immunometabolism. It’s pre-clinical and clinical assets work by reprogramming cellular metabolism and have applications in autoimmune conditions. Istesso’s lead drug, MBS2320, is in a Phase 2a clinical trial in rheumatoid arthritis and has potential applications in other conditions such as ulcerative colitis and […]

Oxbotica

Founded in 2014 on research from Oxford University’s Robotics Institute, Oxbotica’s software uses the latest in computer vision, machine learning and artificial intelligence to enable vehicles to operate autonomously in any environment and on any terrain. This has made it an attractive solution for many enterprises looking to increase efficiency, productivity and safety.

Its control […]

Bramble Energy

Bramble Energy is a UCL and Imperial College London spinout which has developed a unique, patent protected, printed circuit board (PCB) fuel cell – the PCBFC™.

The PCBFC™ utilises cost-effective production methods and materials from the PCB industry to reduce the cost and complexity of manufacturing of proton exchange membrane fuel cells.

Bramble Energy’s ability to leverage […]

Undo

Undo is a Cambridge company whose products transform the way organisations handle software quality issues. Undo helps improve customers’ software quality and productivity, enabling them to fix their ‘unfixable’ bugs, and offers huge improvements in development productivity.

Undo offers a new way of diagnosing and fixing Linux C/C++ application failures using record, rewind and replay technology.

MediaGamma

MediaGamma is a UCL Business spin-out developing  predictive analytics software. The company has developed a world leading enterprise-grade reinforcement machine learning (self-learning) platform, delivering decisions in under five milliseconds. It has proven its technology in programmatic advertising, building and training more accurate user-profiling and bidding algorithms that improve targeting resulting in vastly reduced customer […]

Oxford Flow

Oxford Flow designs and manufactures innovative pressure control equipment using technology developed at the University of Oxford.

Inspiration came to Professor Povey during research into jet turbines. Increasingly frustrated that market-leading pressure regulators couldn’t meet the needs of his R&D, he decided to design his own. The resulting technology set new benchmarks for performance and sustainability.

Oxford […]

OxSyBio

OxSyBio is developing 3D printing techniques to produce a range of tissue-like and functional tissues for medical applications.

The technology is based on cutting-edge research conducted by Professor Hagan Bayley’s group in the Chemistry Department at the University of Oxford. A leader in the exploration of membrane protein structure and function, Professor Bayley’s group developed […]

Dynamic Vision Systems

Dynamic Vision Systems (DVS) is built on collaborative efforts at the University of Manchester and the University of Leeds in the field of smart contact lenses.

The DVS technology arose from discussions between Professor Philip Morgan, Professor Helen Gleeson and Professor Cliff Jones, who have expertise across ophthalmology/optometry, liquid crystals and novel manufacturing. The initial […]

Opsydia

 Opsydia is a spin-out company from the Department of Engineering Science at the University of Oxford, specialising in designing bespoke optical systems and laser fabrication processes for complex and unique ideas.

 

MoA Technology

,

MoA Technology Limited is a plant genetics company spun out from the University of Oxford.

Quantum Motion Technologies

Quantum Motion Technologies was founded on the research undertaken by Professor Simon Benjamin (Department of Materials, Oxford) and Professor John Morton (Department of Engineering Science, Oxford). The company was formed in June 2017, and is aiming to build a universal quantum computer that would be able to tackle the full range of quantum applications.

Paragraf

,

The Parkwalk Opportunities Fund and the Parkwalk-managed University of Cambridge Enterprise Fund V have invested in a £2.64m seed round in Paragraf Limited, a spin-out from the Department of Materials Science at the University of Cambridge.

Paragraf focuses on the production of ‘two-dimensional’ materials, primarily graphene, and the development of devices based on these materials. Using […]

MedaPhor

We are delighted to announce that the Parkwalk Opportunities Fund has participated in the recent financing round of MedaPhor Group plc, the Cardiff University Spin-out and global provider of advanced ultrasound training simulators for medical professionals.

The company is headquartered in Cardiff, UK and Atlanta, USA, with over 500 customers in 45 countries around the […]

Oxford Quantum Circuits

Oxford Quantum Circuits was founded by Professor Peter Leek, who is based at the Clarendon Laboratory Oxford, and is aiming to build a quantum computer based upon a superconducting circuit approach to forming qubits. The intention is to leverage the latest technology in this field and overcome the key challenge that has confounded researchers […]

Creavo Medical Technologies

We are delighted to announce that the Parkwalk Opportunities Fund has made an investment in Creavo Medical Technologies, a University of Leeds Spin-out company, as part of a £13.4 million fundraising.

The round was oversubscribed, exceeded Creavo’s funding target and was strongly supported by existing shareholders including IP Group plc, the University of Leeds, and […]

Predictimmune

, ,

We are delighted to announce that the University of Cambridge Enterprise Fund IV and the Parkwalk Opportunities Fund have closed an investment in Predictimmune Limited, a spinout company from the University of Cambridge. Predictimmune is developing prognostic tests for immune-mediated conditions to aid their management and improve patient outcomes.

Their first offering, PredictImmune-CD, will be […]

Congenica

, ,

We are delighted to announce that the Parkwalk Opportunities Fund and the Parkwalk Technology Fund VII have invested in Congenica Limited, which spun out of the Wellcome Trust Sanger Institute and Department of Health. Congenica has developed software that enables the accurate, rapid and scalable clinical interpretation of genetic and clinical data.

Congenica’s technology is […]

Ilika

Ilika spun out of the University of Southampton’s School of Chemistry in 2004 and quickly established a reputation for the rapid development of novel materials, working with a variety of international companies.

Ilika has a wealth of experience in materials and in working with industrial partners. The company’s novel solid-state battery technology is now close […]

Ceres Power

With technology originating from Imperial College, Ceres Power is a world leader in low cost, next generation fuel cells for use in distributed power products that have the potential to bring cheaper and cleaner energy to homes and businesses. The Group is working with some of the world’s leading companies in order to create […]

Proxisense

,

Proxisense has developed extreme environment proximity sensors and fluid contamination systems utilising eddy current sensors. The former are finding uses in producing systems which monitor the health of turbine blades in real-time, which can extend component lifetimes and reduce maintenance and downtime costs. Proxisense is targeting the power and aerospace industries for these use […]